Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04597372 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2026v9
  2. Primary completion date: Dec 2024 to Dec 2025
    • Site contact updated
    v8
  3. Primary completion date: Aug 2024 to Dec 2024
    • Study completion date: May 2025 to Dec 2025
    • Site contact updated
    v7
  4. Primary completion date: Aug 2023 to Aug 2024
    • Study completion date: May 2024 to May 2025
    v6
  5. Primary completion date: Aug 2022 to Aug 2023
    • Study completion date: May 2023 to May 2024
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2021 to Nov 3, 2021
    • Site details revised
    v4
  2. Start date: Jan 2021 to Aug 2021v3
  3. Start date: Oct 2020 to Jan 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Trial Details
NCT Number NCT04597372
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Johns Hopkins University
Conditions
(from sponsor)		 Urinary Retention Postoperative
Enrollment 154 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov